Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: Evidence from PHYLLIS randomised double blind trial

BMJ (Online)

Volumn 340, Issue 7751, 2010, Pages 846-

  Mancia, Giuseppe ^a,b   Parati, Gianfranco ^a,c   Revera, Miriam ^a,c   Bilo, Grzegorz ^a,c   Giuliano, Andrea ^c   Veglia, Fabrizio ^d   Crepaldi, Gaetano ^e   Zanchetti, Alberto ^c,f  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d CENTRO CARDIOLOGICO MONZINO   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; FOSINOPRIL; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NIFEDIPINE; PLACEBO; PRAVASTATIN;

ADD ON THERAPY; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

AGED; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; DRUG THERAPY, COMBINATION; FEMALE; FOSINOPRIL; HUMANS; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PRAVASTATIN;

EID: 77951073910     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c1197     Document Type: Article

References (36)

1. Riche DM, McClendon KS. Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 2007;64:1603-1610 (Pubitemid 47173538)
2. Chan PS, Nallamothu BK, Gurm HS, Hayward RA, Vijan S. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease. Circulation 2007;115:2398-2409 (Pubitemid 46717962)
3. Ray KK, Cannon CP. Lipid-independent pleiotropic effects of statins in the management of acute coronary syndromes. Curr Treat Options Cardiovasc Med 2007;9:46-51. (Pubitemid 46578388)
4. Ichihara A, Hayashi M, Koura Y, Tada Y, Kaneshiro Y, Saruta T. Long-term effects of statins on arterial pressure and stiffness of hypertensives. J Hum Hypertens 2005;19:103-109 (Pubitemid 40220632)
5. Patterson D, Dick JBC, Struthers AD. Intensive statin treatment improves baroreflex sensitivity: another cardioprotective mechanism for statins? Heart 2002;88:415-416
6. Leibovitz E, Hazanov N, Zimlichman R, Shargorodsky M, Gavish D. Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia. Am J Hypertens 2001;14:1096-1098 (Pubitemid 33033107)
7. Ferrier KE, Muhlmann MH, Baguet JP, Cameron JD, Jennings GL, Dart AM, et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 2002;39:1020-1025
8. Simons LA, Sullivan D, Simons J, Celermajer DS. Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolemia. Atherosclerosis 1998;137:197-203. (Pubitemid 28175392)
9. Laufs U, Wassmann S, Hilgers S, Ribaudo N, Bohm M, Nickening G. Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol 2001;88:1306-1307 (Pubitemid 33132103)
10. Borghi C, Dormi A, Veronesi M, Sangiorgi Z, Gaddi A, on behalf of the Brisighella Heart Study Working Party. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J 2004;148:285-292
11. Kanbay M, Yildirir A, Bozbas H, Ulus T, Bilgi M, Muderrisoglu H, et al. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. Ren Fail 2005;27:297-303. (Pubitemid 40770608)
12. Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Seo YH, et al. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients. Circulation 2004;110:3687-3692
13. Straznicky NE, Howes LG, Lam W, Louis WJ. Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension. Am J Cardiol 1995;75:582-586
14. Glorioso N, Troffa C, Filigheddu F, Dettori F, Soro A, Parpaglia PP, et al. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension 1999;34:1281-1286 (Pubitemid 30002395)
15. Borghi C, Prandin MG, Costa FV, Bacchelli S, Degli Esposti D, Ambrosioni E. Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol 2000;35:549-555 (Pubitemid 30185454)
16. Prasad GV, Ahmed A, Nash MM, Zaltzman JS. Blood pressure reduction with HMG-CoA reductase inhibitors in renal transplant recipients. Kidney Int 2003;63:360-364 (Pubitemid 35463942)
17. Dorval JF, Anderson T, Buithieu J, Chan S, Hutchison S, Huynh T, et al. Reaching recommended lipid and blood pressure targets with amlodipine/ atorvastatin combination in patients with coronary heart disease. Am J Cardiol 2005;95:249-253 (Pubitemid 40092093)
18. Strazzullo P, Kerry SM, Barbato A, Versiero M, D'Elia L, Cappuccio FP. Do statins reduce blood pressure? A meta-analysis of randomized, controlled trials. Hypertension 2007;49:792-798 (Pubitemid 351664226)
19. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003;21:821-848 (Pubitemid 36677141)
20. Parati G, Bilo G, Mancia G. Prognostic and diagnostic value of ambulatory blood pressure monitoring. In: Oparil S, Weber MA (eds). Hypertension: companion to Brenner & Rector's 'The kidney'. Elsevier Saunders, 2005.
21. Mancia G, Parati G. Guiding antihypertensive treatment decisions using ambulatory blood pressure monitoring. Curr Hypertens Rep 2006;8:330-337 (Pubitemid 44268837)
22. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-1158 (Pubitemid 36398384)
23. Zanchetti A, Crepaldi G, Bond MG, Gallus G, Veglia F, Mancia G, et al. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS - a randomized double-blind trial. Stroke 2004;35;2807-2812 (Pubitemid 39565175)
24. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, et al. AHA dietary guidelines - revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102;2284-2299 (Pubitemid 29416243)
25. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 2001;322:531-536
26. O'Brien E, Pickering T, Asmar R, Myers M, Parati G, Staessen J, et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit 2002;7:3-17. (Pubitemid 34304045)
27. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, et al. Blood pressure and heart rate variability in normotensive and hypertensive human beings. Circ Res 1983;53:96-104. (Pubitemid 13031772)
28. Staessen JA, Thijs L, Fagard R, O'Brien E, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional versus ambulatory blood pressure in older patientswith hypertension. JAMA 1999;282:539-546 (Pubitemid 29380290)
29. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987;5:93-98 (Pubitemid 17058039)
30. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007;49:1265-1270 (Pubitemid 46809367)
31. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187 (Pubitemid 46924065)
32. Bautista LE. Blood pressure-lowering effects of statins: who benefits? J Hypertens 2009;27:1478-1484
33. Zhou Z, Rahme E, Pilote L. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. Am Heart J 2006;151:273-281 (Pubitemid 43144726)
34. Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH. Reduction in blood pressure with statins: results fromthe UCSD Statin Study, a randomized trial. Arch Intern Med 2008;168:721-727
35. Tonelli M, Sacks F, Pfeffer M, Lopez-Jimenez F, Jhangri GS, Curhan G. Effect of pravastatin on blood pressure in people with cardiovascular disease. J Hum Hypertens 2006;20:560-565 (Pubitemid 44088957)
36. Williams B, Lacy PS, Cruickshank JK, Collier D, Hughes AD, Stanton A, et al. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation - Lipid-Lowering Arm (CAFE-LLA) Study. Circulation 2009;119:53-61.